提供支持According to 36Kr.com, Sanyou Biomedicine (Shanghai) Co., Ltd. ("Sanyou Bio") has raised tens of millions of yuan in its Series A round, with participation from Haier Medical, the medical platform of Haier Financial Holdings, and Liferiver Bio-Tech.
Proceeds from this round will be used to upgrade the large capacity holistic and bi-specific antibody phage display libraries, improve the pharmacodynamics service platform of drugs, build platforms for the researches of drug quality and technology, and cell lines for production, and advance the preclinical researches of several anti-tumor antibodies.
Founded in 2015, Sanyou Bio is a biotechnology company focusing on the research and development of innovative antibodies and related services. The company mainly provides the corresponding R&D solutions for biopharmaceutical enterprises. It cooperates with clients to develop monoclonal antibodies in two modes: One is providing customers with R&D outsourcing services by utilizing the leading antibody library and R&D capabilities. The other is transferring the authorization to the customer after self-development or cooperative development of antibodies.
At present, Sanyou Bio has set up an R&D laboratory for innovative antibodies in "Shanghai Caohejing National High-Tech Park" with advanced facilities, covering thousands of square meters. Sanyou Bio has several technology platforms of drug discovery, antibody engineering, in vivo and in vitro efficacy testing, chemogenomic analysis, cell line construction for production, and process development in production.
The multiple antibody libraries launched by Sanyou Bio in December 2017 can provide comprehensive solutions for human, mouse, and alpaca antibodies. These three types of antibodies cover almost all the varieties currently under development.
Up to now, Sanyou Bio has provided hundreds of projects and technology support of antibody drugs for more than 100 domestic and foreign companies, including traditional drug giants after transformation, emerging biotechnology companies, and well-known research institutions. It has completed hundreds of antibody screening tests and dozens of innovative antibody drug discovery projects.
About Haier Medical
Established in 2014, Haier Medical is a wholly-owned subsidiary of Haier Group and adheres to Haier's strategic mission of comprehensively entering the healthcare industry. Haier Medical is committed to improving home medical and mobile medical services and building an intelligent health management ecosystem.
Liferiver is a leading PCR-based molecular diagnostic solution provider, developing, manufacturing & marketing real-time PCR diagnostic kits as well as instruments. The company offers over 400 testing kits covering most infectious diseases, genetic diseases, tumors, organ transplants and others. Its kits are compatible with most real-time PCR systems of various brands including ABI, Bio-Rad, and Roche.
渝公网安备 50011202502165号
